These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 8872134)
1. Reexamination of the extent of the activation of Lys78 plasminogen by tissue plasminogen activator in the presence of polymerized fibrin. Urano T; Takada Y; Ihara H; Takada A Haemostasis; 1996; 26(4):220-7. PubMed ID: 8872134 [TBL] [Abstract][Full Text] [Related]
2. The course and prerequisites of Lys-plasminogen formation during fibrinolysis. Suenson E; Thorsen S Biochemistry; 1988 Apr; 27(7):2435-43. PubMed ID: 3382632 [TBL] [Abstract][Full Text] [Related]
3. Stimulation of tPA-dependent provisional extracellular fibrin matrix degradation by human recombinant soluble melanotransferrin. Bertrand Y; Demeule M; Rivard GE; Béliveau R Biochim Biophys Acta; 2006 Oct; 1763(10):1024-30. PubMed ID: 16979249 [TBL] [Abstract][Full Text] [Related]
4. The effect of polymerised fibrin on the catalytic activities of one-chain tissue-type plasminogen activator as revealed by an analogue resistant to plasmin cleavage. Petersen LC; Johannessen M; Foster D; Kumar A; Mulvihill E Biochim Biophys Acta; 1988 Feb; 952(3):245-54. PubMed ID: 2962643 [TBL] [Abstract][Full Text] [Related]
5. A comparative study of amyloid-beta (1-42) as a cofactor for plasminogen activation by vampire bat plasminogen activator and recombinant human tissue-type plasminogen activator. Kruithof EK; Schleuning WD Thromb Haemost; 2004 Sep; 92(3):559-67. PubMed ID: 15351852 [TBL] [Abstract][Full Text] [Related]
6. Elimination of the Cys558-Cys566 bond in Lys78-plasminogen--effect on activation and fibrin interaction. Linde V; Nielsen LS; Foster DC; Petersen LC Eur J Biochem; 1998 Jan; 251(1-2):472-9. PubMed ID: 9492320 [TBL] [Abstract][Full Text] [Related]
7. The mechanism of activation of plasminogen at the fibrin surface by tissue-type plasminogen activator in a plasma milieu in vitro. Role of alpha 2-antiplasmin. Rouy D; Anglés-Cano E Biochem J; 1990 Oct; 271(1):51-7. PubMed ID: 1699517 [TBL] [Abstract][Full Text] [Related]
8. Fluorogenic fibrinogen and fibrin facilitate macromolecular assembly and dynamic assay of picomolar levels of plasminogen activators under well mixed conditions. Wu JH; Diamond SL Thromb Haemost; 1995 Aug; 74(2):711-7. PubMed ID: 8585011 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of the factors contributing to fibrin-dependent plasminogen activation. Mosesson MW; Siebenlist KR; Voskuilen M; Nieuwenhuizen W Thromb Haemost; 1998 Apr; 79(4):796-801. PubMed ID: 9569195 [TBL] [Abstract][Full Text] [Related]
10. The kinetics of plasminogen activation by thrombin-cleaved pro-urokinase and promotion of its activity by fibrin fragment E-2 and by tissue plasminogen activator. Liu JN; Gurewich V Blood; 1993 Feb; 81(4):980-7. PubMed ID: 8428004 [TBL] [Abstract][Full Text] [Related]
11. A steady-state template model that describes the kinetics of fibrin-stimulated [Glu1]- and [Lys78]plasminogen activation by native tissue-type plasminogen activator and variants that lack either the finger or kringle-2 domain. Horrevoets AJ; Pannekoek H; Nesheim ME J Biol Chem; 1997 Jan; 272(4):2183-91. PubMed ID: 9036151 [TBL] [Abstract][Full Text] [Related]
12. A comparative study of the promotion of tissue plasminogen activator and pro-urokinase-induced plasminogen activation by fragments D and E-2 of fibrin. Liu JN; Gurewich V J Clin Invest; 1991 Dec; 88(6):2012-7. PubMed ID: 1836471 [TBL] [Abstract][Full Text] [Related]
13. Mechanism of potentiation of tissue-type plasminogen activator. Lazos SA; Wong SS Biochem Mol Biol Int; 1995 Dec; 37(6):1071-77. PubMed ID: 8747537 [TBL] [Abstract][Full Text] [Related]
14. On the molecular interactions between fibrin, tissue-type plasminogen activator and plasminogen. Lijnen HR; Van Hoef B; Collen D Thromb Res Suppl; 1990; 10():45-54. PubMed ID: 2107598 [TBL] [Abstract][Full Text] [Related]
15. The role of fragment X polymers in the fibrin enhancement of tissue plasminogen activator-catalyzed plasmin formation. Suenson E; Bjerrum P; Holm A; Lind B; Meldal M; Selmer J; Petersen LC J Biol Chem; 1990 Dec; 265(36):22228-37. PubMed ID: 2148318 [TBL] [Abstract][Full Text] [Related]
16. Comparison of kinetic parameters of the activation of Glu-plasminogen by tissue plasminogen activator obtained from various sources. Takada A; Sugawara Y; Takada Y Haemostasis; 1988; 18(2):117-25. PubMed ID: 3137140 [TBL] [Abstract][Full Text] [Related]
17. Vampire bat salivary plasminogen activator exhibits a strict and fastidious requirement for polymeric fibrin as its cofactor, unlike human tissue-type plasminogen activator. A kinetic analysis. Bergum PW; Gardell SJ J Biol Chem; 1992 Sep; 267(25):17726-31. PubMed ID: 1387641 [TBL] [Abstract][Full Text] [Related]
18. Glu-plasminogen I and II: their activation by urokinase and streptokinase in the presence of fibrin and fibrinogen. Takada Y; Makino Y; Takada A Thromb Res; 1985 Aug; 39(3):289-96. PubMed ID: 4049320 [TBL] [Abstract][Full Text] [Related]
19. Effect of fibrin-like stimulators on the activation of plasminogen by tissue-type plasminogen activator (t-PA)--studies with active site mutagenized plasminogen and plasmin resistant t-PA. Lijnen HR; Van Hoef B; De Cock F; Collen D Thromb Haemost; 1990 Aug; 64(1):61-8. PubMed ID: 2148848 [TBL] [Abstract][Full Text] [Related]
20. Enhancement of the activation of Glu-plasminogen by urokinase in the simultaneous presence of tranexamic acid or fibrin. Takada A; Sugawara Y; Takada Y Haemostasis; 1989; 19(1):26-31. PubMed ID: 2920977 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]